3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
6
Sarcoma
4
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Glioblastoma
2
Endometrial Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Meningioma
1
Male Urogenital Diseases
1
Lung Neoplasms
1
Locally Recurrent Rectal Cancer
1
Head and Neck Neoplasms
1
Female Urogenital Diseases
1
Interventions
Temozolomide
6
Cyclophosphamide
5
cabozantinib
4
Vincristine
4
fludarabine
3
Radiotherapy
3
Irinotecan
3
liposomal doxorubicin
2
irinotecan sucrosofate
2
Zoledronic Acid
2
Topotecan
2
Specimen Handling
2
PM 01183
2
Ifosfamide
2
Etoposide
2
Eflornithine
2
Drug Therapy
2
Doxorubicin
2
trilaciclib
1
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
naxitamab
1
fluzoparib
1
fludarabine phosphate
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma, Ewing
×
Radiation Dose Hypofractionation
×
Clear all
NCT07188532
2026-06-04
BEAR
Mayo Clinic
Phase NA
Recruiting
141 enrolled